Associations between patient portal use and electronic health record (EHR) data timeliness in type 2 diabetes mellitus care.

IF 1.8 Q4 ENDOCRINOLOGY & METABOLISM
Journal of Diabetes and Metabolic Disorders Pub Date : 2024-07-31 eCollection Date: 2024-12-01 DOI:10.1007/s40200-024-01468-6
Kevin Wiley, Justin Blackburn, Eneida Mendonca, Nir Menachemi, Mary De Groot, Joshua R Vest
{"title":"Associations between patient portal use and electronic health record (EHR) data timeliness in type 2 diabetes mellitus care.","authors":"Kevin Wiley, Justin Blackburn, Eneida Mendonca, Nir Menachemi, Mary De Groot, Joshua R Vest","doi":"10.1007/s40200-024-01468-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Patient data is subject to missingness and errors. Patient portals enable patients managing type 2 diabetes mellitus (T2DM) to review and correct data to avoid retesting, medication errors, and diagnostic mistakes. We examined whether patient portal use was associated with electronic health record (EHR) data timeliness in T2DM care.</p><p><strong>Research design and methods: </strong>We analyzed EHR data from a panel of adult patients to determine whether portal use improved data timeliness. EHR data timeliness is measured as the number of days between patient encounters, accounting for mean attribute update periods, where available EHR attribute updates for T2DM measurements were present, including body mass, weight, glycated hemoglobin A1c, cholesterol, blood pressure, serum creatinine, and smoking status. We performed negative binomial regressions with fixed effects to estimate the association between patient portal use and EHR data timeliness. Sensitivity analyses were conducted using Poisson regressions.</p><p><strong>Results: </strong>Nearly a third (31.3%) of patients in our sample actively used the health portal. There were fewer days (111.9 days vs. 136.7 days; <i>p</i> < 0.001) between EHR attribute updates for patients who used health portals compared to patients who did not. Data timeliness was lower among female, non-Hispanic White Medicare beneficiaries. Based on regression analyses, portal use was associated with an expected 3.6 (<i>p</i> < 0.001) percentage point decrease in days between attribute updates, indicating improved EHR timeliness.</p><p><strong>Conclusion: </strong>Improving the quality of health information may streamline decision-making in partnership with patients who produce data points across clinical settings. Active use of patient portals and digital health tools in chronic disease care are critical for care management and clinical decision-making, especially for patients managing type 2 diabetes across clinical settings.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s40200-024-01468-6.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"23 2","pages":"2073-2080"},"PeriodicalIF":1.8000,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11599696/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes and Metabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40200-024-01468-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Patient data is subject to missingness and errors. Patient portals enable patients managing type 2 diabetes mellitus (T2DM) to review and correct data to avoid retesting, medication errors, and diagnostic mistakes. We examined whether patient portal use was associated with electronic health record (EHR) data timeliness in T2DM care.

Research design and methods: We analyzed EHR data from a panel of adult patients to determine whether portal use improved data timeliness. EHR data timeliness is measured as the number of days between patient encounters, accounting for mean attribute update periods, where available EHR attribute updates for T2DM measurements were present, including body mass, weight, glycated hemoglobin A1c, cholesterol, blood pressure, serum creatinine, and smoking status. We performed negative binomial regressions with fixed effects to estimate the association between patient portal use and EHR data timeliness. Sensitivity analyses were conducted using Poisson regressions.

Results: Nearly a third (31.3%) of patients in our sample actively used the health portal. There were fewer days (111.9 days vs. 136.7 days; p < 0.001) between EHR attribute updates for patients who used health portals compared to patients who did not. Data timeliness was lower among female, non-Hispanic White Medicare beneficiaries. Based on regression analyses, portal use was associated with an expected 3.6 (p < 0.001) percentage point decrease in days between attribute updates, indicating improved EHR timeliness.

Conclusion: Improving the quality of health information may streamline decision-making in partnership with patients who produce data points across clinical settings. Active use of patient portals and digital health tools in chronic disease care are critical for care management and clinical decision-making, especially for patients managing type 2 diabetes across clinical settings.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-024-01468-6.

2型糖尿病患者门户网站使用与电子健康记录(EHR)数据及时性之间的关系
目的:患者资料容易丢失和错误。患者门户使管理2型糖尿病(T2DM)的患者能够审查和纠正数据,以避免重测、用药错误和诊断错误。我们研究了T2DM患者门户网站的使用是否与电子健康记录(EHR)数据的及时性相关。研究设计和方法:我们分析了一组成年患者的电子病历数据,以确定门户网站的使用是否提高了数据的及时性。EHR数据的时效性是通过患者就诊之间的天数来衡量的,考虑到平均属性更新周期,其中存在可用于T2DM测量的EHR属性更新,包括体重、体重、糖化血红蛋白A1c、胆固醇、血压、血清肌酐和吸烟状况。我们采用固定效应的负二项回归来估计患者门户网站使用与电子病历数据及时性之间的关系。采用泊松回归进行敏感性分析。结果:在我们的样本中,近三分之一(31.3%)的患者积极使用健康门户网站。天数较少(111.9天比136.7天;结论:提高健康信息的质量可以简化与临床环境中产生数据点的患者的合作决策。在慢性病护理中积极使用患者门户网站和数字健康工具对于护理管理和临床决策至关重要,特别是对于在临床环境中管理2型糖尿病的患者。补充资料:在线版本提供补充资料,网址为10.1007/s40200-024-01468-6。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Diabetes and Metabolic Disorders
Journal of Diabetes and Metabolic Disorders Medicine-Internal Medicine
CiteScore
4.80
自引率
3.60%
发文量
210
期刊介绍: Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of endocrinology and provides a forum of debate of the highest quality on these issues. Topics of interest include, but are not limited to, diabetes, lipid disorders, metabolic disorders, osteoporosis, interdisciplinary practices in endocrinology, cardiovascular and metabolic risk, aging research, obesity, traditional medicine, pychosomatic research, behavioral medicine, ethics and evidence-based practices.As of Jan 2018 the journal is published by Springer as a hybrid journal with no article processing charges. All articles published before 2018 are available free of charge on springerlink.Unofficial 2017 2-year Impact Factor: 1.816.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信